Ledger.Open graph →
SEC Form D · filed February 22, 2021

EpiVax Therapeutics, Inc

Offering
$370K
Sold
$370K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Providence, RI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Nicholas W. Hauser · NEW YORK, NYDirectorRichard Lipkin · Providence, RIDirectorJoshua N. Baer · Beaverton, ORDirectorRichard L. Chilton · Stamford, CTExec · DirectorWilliam Martin · Providence, RIExec · DirectorAnne De Groot · Providence, RIExec · DirectorChilton Investment Services, LLC · Stamford, CTExec · DirectorPolina W. Kushelev · NEW YORK, NYDirectorDaniel Adams · Providence, RIDirectorSusan E. Lattman · Basking Ridge, NJExec · DirectorAndrew Clark · Duxbury, MAExec · DirectorAileen Lee · Palo Alto, CADirectorClifford Grimm · Providence, RIExecStephen P. Schuler · Chicago, ILExecAlun Williams · NEW YORK, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗